In glioblastoma, LAG-3 is expressed along with CD8A, suggesting that LAG-3 targeted therapy in glioblastoma with sufficient CD8+ T cell infiltration may be hopeful.75, 76, 77, 78, 79. This evidence concerns the gene CD8A and glioblastoma.